US 11,723,676 B2
Joint instrumentation and associated methods of use
Thomas Loring, Philadelphia, PA (US); Chulho Pak, Mahwah, NJ (US); Victor Chan, Landing, NJ (US); and Ryan Sellman, Carlisle, PA (US)
Assigned to ENCORE MEDICAL, L.P., Austin, TX (US)
Filed by Encore Medical, LP, Austin, TX (US)
Filed on Apr. 14, 2021, as Appl. No. 17/230,158.
Application 17/230,158 is a division of application No. 16/223,864, filed on Dec. 18, 2018, granted, now 11,000,296.
Claims priority of provisional application 62/673,285, filed on May 18, 2018.
Claims priority of provisional application 62/608,252, filed on Dec. 20, 2017.
Prior Publication US 2021/0290412 A1, Sep. 23, 2021
Int. Cl. A61F 2/46 (2006.01); A61F 2/42 (2006.01); A61B 17/17 (2006.01); A61F 2/30 (2006.01); A61B 17/15 (2006.01)
CPC A61B 17/17 (2013.01) [A61B 17/1775 (2016.11); A61F 2/4606 (2013.01); A61F 2/4657 (2013.01); A61F 2/4684 (2013.01); A61B 17/15 (2013.01); A61F 2/4202 (2013.01); A61F 2002/30878 (2013.01); A61F 2002/4205 (2013.01); A61F 2002/4207 (2013.01); A61F 2002/4668 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A trial implant, comprising:
a central portion, comprising:
a top articulating surface extending between a first end and a second end and having a convex shape,
a bottom surface configured to at least partially contact a first resected surface of a bone, and
a first side surface extending between the top articulating surface and the bottom surface, the first side surface being sloped such that a width of the top articulating surface is greater than a width of the bottom surface; and
a first outer portion extending laterally from the central portion,
wherein the first side surface and the first outer portion are separated by a first opening shaped such that up to four resected surfaces of the bone are visible when the trial implant is seated on the bone.